Dublin, May 21, 2026 (GLOBE NEWSWIRE) -- The "Upstream and Downstream Manufacturing in the Biopharmaceutical Industry (June 11, 2026)" training has been added to ResearchAndMarkets.com's offering.

An Open Approach for a Smart and Affordable Bioprocess Control System The goal for upstream bioprocess development is to support and maintain the ability to rapidly develop and maintain manufacturing ...

Downstream purification continues to pressure the biopharmaceutical manufacturing industry from a capacity standpoint, with recent increases in upstream yield and titers overcoming the relatively slow ...

Scaling a viral vector process from benchtop to clinical supply isn't a bigger version of monoclonal antibody (mAb) manufacturing, but an entirely different analytical challenge. Cell and gene therapy ...

Scientist - Tumor Biology, Department for Human and Animal Cell Lines, Leibniz Institute DSMZ (German Collection of microorganisms and cell cultures) In the last decades, the upstream processing in ...